Skybiotech Healthcare opened lower at -, compared with its previous close of ₹114.00. During today's session, the stock has traded between - and -, with an average traded price of -. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Skybiotech Healthcare is now worth
₹ 37,097.00
Giving a profit of
₹ 27,097.00 (270.97%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.00 (+0.00%)
Day High
-
Day Low
-
Day Open
-
Prev Close
₹114.00
Volume
-
Value Traded
-
1W Return
-0.87%
1M Return
-2.14%
3M Return
-30.40%
6M Return
-17.93%
1Y Return
-22.50%
Market Cap (₹ Cr.)
22
PE Ratio
-10.10
PB Ratio
3.07
Dividend Yield
-
ROE
-12.07%
ROCE
-9.40%
Book Value (₹)
37.10
Face Value (₹)
10.00
EPS (TTM)
-2.91
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-0.87%
6 Weeks
-
1 Month
-2.14%
3 Months
-30.40%
9 Months
-18.54%
Skybiotech Healthcare Q2FY27 Results: Consolidated loss widens 158% YoY
Consolidated net loss widened to ₹79.92 lakh in Q2FY27 from ₹30.97 lakh in Q2FY26. Standalone net profit rose 50% YoY to ₹1.76 lakh, driven entirely by other income. Consolidated revenue from operations fell 45.8% YoY to ₹103.89 lakh. Employee benefits expense at consolidated level increased to ₹45.24 lakh in Q2FY27.
2 days agoSkybiotech Healthcare ratifies name change compliance, approves FY26 accounts
Skybiotech Healthcare ratified rectification of SEBI LODR non-compliance regarding its name change from Kapil Cotex. Audited standalone and consolidated financial statements for FY26 were adopted by shareholders. M/s. SPD & Associates appointed as statutory auditor replacing previous engagement. Mr. Prakashchandra Rathi re-appointed as director retiring by rotation.
1mo agoSkybiotech Healthcare schedules 43rd AGM for September 30, 2026
Skybiotech Healthcare holds its 43rd AGM on September 30, 2026, in Aurangabad. Shareholders to adopt standalone and consolidated financials for FY26. M/s. SPD & Associates appointed as statutory auditors for five years. E-voting open from September 26 to 29, 2026, via NSDL platform.
2mo agoSkybiotech Healthcare narrows consolidated loss to ₹111.68 lakh in FY26
Skybiotech Healthcare Limited narrowed its consolidated net loss to ₹111.68 lakh for FY26 from ₹236.89 lakh in FY25. Total income decreased marginally to ₹740.38 lakh, while total expenses reduced to ₹907.04 lakh. On a standalone basis, the company reported a net loss of ₹6.03 lakh compared to a net profit of ₹5.96 lakh in the previous year.
5mo agoSkybiotech Healthcare Limited Submits Q4 FY26 Compliance Certificate to BSE
Skybiotech Healthcare Limited (formerly Kapil Cotex Limited) submitted its Q4 FY26 compliance certificate to BSE under SEBI Regulation 74(5) on 09th April, 2026. The certificate from registrar Satellite Corporate Services Pvt. Ltd. confirmed no physical share certificates were received for dematerialization during the quarter ended 31st March, 2026, demonstrating the company's adherence to regulatory compliance requirements.
7mo agoSkybiotech Healthcare Limited Announces Q3 FY26 Financial Results
Skybiotech Healthcare Limited announced unaudited financial results for Q3 FY26 quarter ended December 31, 2025. The Board approved standalone and consolidated results on February 14, 2026. The company completed its name change from Kapil Cotex Limited effective November 7, 2025, operating as a single-segment business under BSE script code 512036.
9mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,182.60 | +2.85% | ₹40,422.92 | 37.90 | +8.57% | |
| ₹31,705.00 | -0.46% | ₹35,363.36 | 47.30 | -22.14% | |
| ₹250.94 | +1.34% | ₹23,707.62 | 53.00 | +80.12% | |
| ₹521.50 | +0.29% | ₹15,101.43 | 14.60 | +16.58% | |
| ₹506.70 | +0.07% | ₹13,784.30 | 29.00 | +52.37% | |
| ₹1,351.60 | -1.36% | ₹12,486.23 | 35.60 | +59.61% | |
| ₹23.62 | -0.63% | ₹12,036.65 | 25.30 | -18.33% | |
| ₹549.70 | -1.12% | ₹10,887.05 | 45.20 | +75.12% | |
| ₹727.95 | +1.20% | ₹7,108.31 | 29.70 | +0.74% | |
| ₹414.50 | -0.07% | ₹5,863.53 | 28.30 | +3.34% | |
| ₹549.50 | +0.01% | ₹5,769.28 | 35.10 | +31.15% | |
| ₹676.10 | +0.77% | ₹4,954.30 | 36.20 | -25.87% |
An investment of ₹10,000 made 5 years ago in Skybiotech Healthcare is now worth
₹ 37,097.00
Giving a profit of
₹ 27,097.00 (270.97%)
Note: Past profits do not guarantee future returns.
